Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

miRMap: Profiling 14q32 microRNA Expression and DNA Methylation Throughout the Human Vasculature.

Goossens EAC, de Vries MR, Simons KH, Putter H, Quax PHA, Nossent AY.

Front Cardiovasc Med. 2019 Aug 8;6:113. doi: 10.3389/fcvm.2019.00113. eCollection 2019.

2.

Akkermansia muciniphila Exerts Lipid-Lowering and Immunomodulatory Effects without Affecting Neointima Formation in Hyperlipidemic APOE*3-Leiden.CETP Mice.

Katiraei S, de Vries MR, Costain AH, Thiem K, Hoving LR, van Diepen JA, Smits HH, Bouter KE, Rensen PCN, Quax PHA, Nieuwdorp M, Netea MG, de Vos WM, Cani PD, Belzer C, van Dijk KW, Berbée JFP, van Harmelen V.

Mol Nutr Food Res. 2019 Aug 6:e1900732. doi: 10.1002/mnfr.201900732. [Epub ahead of print]

PMID:
31389129
3.

Variations in Surgical Procedures for Inducing Hind Limb Ischemia in Mice and the Impact of These Variations on Neovascularization Assessment.

Aref Z, de Vries MR, Quax PHA.

Int J Mol Sci. 2019 Jul 29;20(15). pii: E3704. doi: 10.3390/ijms20153704. Review.

4.

CD8+ T Cells Protect During Vein Graft Disease Development.

Simons KH, de Vries MR, Peters HAB, Jukema JW, Quax PHA, Arens R.

Front Cardiovasc Med. 2019 Jun 13;6:77. doi: 10.3389/fcvm.2019.00077. eCollection 2019.

5.

Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3-Leiden mice following myocardial ischemia-reperfusion injury.

Pluijmert NJ, den Haan MC, van Zuylen VL, Steendijk P, de Boer HC, van Zonneveld AJ, Fibbe WE, Schalij MJ, Quax PHA, Atsma DE.

PLoS One. 2019 Jun 14;14(6):e0217582. doi: 10.1371/journal.pone.0217582. eCollection 2019.

6.

Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis.

Kritikou E, Depuydt MAC, de Vries MR, Mulder KE, Govaert AM, Smit MD, van Duijn J, Foks AC, Wezel A, Smeets HJ, Slütter B, Quax PHA, Kuiper J, Bot I.

Cells. 2019 Apr 9;8(4). pii: E334. doi: 10.3390/cells8040334.

7.

IRF3 and IRF7 mediate neovascularization via inflammatory cytokines.

Simons KH, de Vries MR, de Jong RCM, Peters HAB, Jukema JW, Quax PHA.

J Cell Mol Med. 2019 Jun;23(6):3888-3896. doi: 10.1111/jcmm.14247. Epub 2019 Apr 1.

8.

Short-Term Preoperative Protein Restriction Attenuates Vein Graft Disease via Induction of Cystathionine ϒ-Lyase.

Trocha KM, Kip P, Tao M, MacArthur MR, Treviño-Villarreal H, Longchamp A, Toussaint W, Lambrecht BN, de Vries MR, Quax PHA, Mitchell JR, Ozaki CK.

Cardiovasc Res. 2019 Mar 29. pii: cvz086. doi: 10.1093/cvr/cvz086. [Epub ahead of print]

PMID:
30924866
9.

Corrigendum to "Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients" [Int. J. Cardiol. 124 (2008) 166-171].

van der Hoeven BL, Pires NMM, Warda HM, Putter H, Quax PHA, Schalij MJ, Jukema JW.

Int J Cardiol. 2019 Jul 15;287:211. doi: 10.1016/j.ijcard.2019.02.049. Epub 2019 Mar 22. No abstract available.

PMID:
30910285
10.

T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword.

Simons KH, de Jong A, Jukema JW, de Vries MR, Arens R, Quax PHA.

Nat Rev Cardiol. 2019 Jun;16(6):325-343. doi: 10.1038/s41569-019-0164-7. Review.

PMID:
30770894
11.

Metabolic Alterations in Cardiopulmonary Vascular Dysfunction.

Smolders VF, Zodda E, Quax PHA, Carini M, Barberà JA, Thomson TM, Tura-Ceide O, Cascante M.

Front Mol Biosci. 2019 Jan 22;5:120. doi: 10.3389/fmolb.2018.00120. eCollection 2018. Review.

12.

Posttranscriptional Regulation of 14q32 MicroRNAs by the CIRBP and HADHB during Vascular Regeneration after Ischemia.

Downie Ruiz Velasco A, Welten SMJ, Goossens EAC, Quax PHA, Rappsilber J, Michlewski G, Nossent AY.

Mol Ther Nucleic Acids. 2019 Mar 1;14:329-338. doi: 10.1016/j.omtn.2018.11.017. Epub 2018 Dec 6.

13.

Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in human cardiovascular disease.

Håkansson KEJ, Goossens EAC, Trompet S, van Ingen E, de Vries MR, van der Kwast RVCT, Ripa RS, Kastrup J, Hohensinner PJ, Kaun C, Wojta J, Böhringer S, Le Cessie S, Jukema JW, Quax PHA, Nossent AY.

Cardiovasc Res. 2019 Aug 1;115(10):1519-1532. doi: 10.1093/cvr/cvy309.

PMID:
30544252
14.

The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy.

Brinks J, van Dijk EHC, Habeeb M, Nikolaou A, Tsonaka R, Peters HAB, Sips HCM, van de Merbel AF, de Jong EK, Notenboom RGE, Kielbasa SM, van der Maarel SM, Quax PHA, Meijer OC, Boon CJF.

Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5682-5692. doi: 10.1167/iovs.18-25054.

PMID:
30489628
15.

Circulating Small Non-coding RNAs as Biomarkers for Recovery After Exhaustive or Repetitive Exercise.

Håkansson KEJ, Sollie O, Simons KH, Quax PHA, Jensen J, Nossent AY.

Front Physiol. 2018 Aug 22;9:1136. doi: 10.3389/fphys.2018.01136. eCollection 2018.

16.

Blockade of vascular endothelial growth factor receptor 2 inhibits intraplaque haemorrhage by normalization of plaque neovessels.

de Vries MR, Parma L, Peters HAB, Schepers A, Hamming JF, Jukema JW, Goumans MJTH, Guo L, Finn AV, Virmani R, Ozaki CK, Quax PHA.

J Intern Med. 2019 Jan;285(1):59-74. doi: 10.1111/joim.12821. Epub 2018 Sep 7.

17.

Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner.

Amersfoort J, Schaftenaar FH, Douna H, van Santbrink PJ, Kröner MJ, van Puijvelde GHM, Quax PHA, Kuiper J, Bot I.

Atherosclerosis. 2018 Aug;275:214-224. doi: 10.1016/j.atherosclerosis.2018.06.015. Epub 2018 Jun 13.

18.

Relaxin receptor deficiency promotes vascular inflammation and impairs outward remodeling in arteriovenous fistulas.

Bezhaeva T, de Vries MR, Geelhoed WJ, van der Veer EP, Versteeg S, van Alem CMA, Voorzaat BM, Eijkelkamp N, van der Bogt KE, Agoulnik AI, van Zonneveld AJ, Quax PHA, Rotmans JI.

FASEB J. 2018 Jun 8:fj201800437R. doi: 10.1096/fj.201800437R. [Epub ahead of print]

19.

Systemic Upregulation of IL-10 (Interleukin-10) Using a Nonimmunogenic Vector Reduces Growth and Rate of Dissecting Abdominal Aortic Aneurysm.

Adam M, Kooreman NG, Jagger A, Wagenhäuser MU, Mehrkens D, Wang Y, Kayama Y, Toyama K, Raaz U, Schellinger IN, Maegdefessel L, Spin JM, Hamming JF, Quax PHA, Baldus S, Wu JC, Tsao PS.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1796-1805. doi: 10.1161/ATVBAHA.117.310672.

20.

The protective role of Toll-like receptor 3 and type-I interferons in the pathophysiology of vein graft disease.

Simons KH, de Vries MR, Peters HAB, Hamming JF, Jukema JW, Quax PHA.

J Mol Cell Cardiol. 2018 Aug;121:16-24. doi: 10.1016/j.yjmcc.2018.06.001. Epub 2018 Jun 4.

PMID:
29879406
21.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 Aug;21(3):425-532. doi: 10.1007/s10456-018-9613-x. Review.

22.

Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response.

de Jong RCM, Pluijmert NJ, de Vries MR, Pettersson K, Atsma DE, Jukema JW, Quax PHA.

Sci Rep. 2018 Apr 30;8(1):6753. doi: 10.1038/s41598-018-25143-y.

23.

The role of CD27-CD70-mediated T cell co-stimulation in vasculogenesis, arteriogenesis and angiogenesis.

Simons KH, Aref Z, Peters HAB, Welten SP, Nossent AY, Jukema JW, Hamming JF, Arens R, de Vries MR, Quax PHA.

Int J Cardiol. 2018 Jun 1;260:184-190. doi: 10.1016/j.ijcard.2018.02.015.

24.

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo.

Kooreman NG, Kim Y, de Almeida PE, Termglinchan V, Diecke S, Shao NY, Wei TT, Yi H, Dey D, Nelakanti R, Brouwer TP, Paik DT, Sagiv-Barfi I, Han A, Quax PHA, Hamming JF, Levy R, Davis MM, Wu JC.

Cell Stem Cell. 2018 Apr 5;22(4):501-513.e7. doi: 10.1016/j.stem.2018.01.016. Epub 2018 Feb 15.

25.

Inflammation in Vein Graft Disease.

de Vries MR, Quax PHA.

Front Cardiovasc Med. 2018 Jan 24;5:3. doi: 10.3389/fcvm.2018.00003. eCollection 2018. Review.

26.

The Prebiotic Inulin Aggravates Accelerated Atherosclerosis in Hypercholesterolemic APOE*3-Leiden Mice.

Hoving LR, de Vries MR, de Jong RCM, Katiraei S, Pronk A, Quax PHA, van Harmelen V, Willems van Dijk K.

Nutrients. 2018 Feb 3;10(2). pii: E172. doi: 10.3390/nu10020172.

27.

Adenosine-to-Inosine Editing of MicroRNA-487b Alters Target Gene Selection After Ischemia and Promotes Neovascularization.

van der Kwast RVCT, van Ingen E, Parma L, Peters HAB, Quax PHA, Nossent AY.

Circ Res. 2018 Feb 2;122(3):444-456. doi: 10.1161/CIRCRESAHA.117.312345. Epub 2017 Dec 28.

PMID:
29284691
28.

The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development.

de Jong RCM, Ewing MM, de Vries MR, Karper JC, Bastiaansen AJNM, Peters HAB, Baghana F, van den Elsen PJ, Gongora C, Jukema JW, Quax PHA.

PLoS One. 2017 Oct 10;12(10):e0185820. doi: 10.1371/journal.pone.0185820. eCollection 2017.

29.

Deficiency of TLR4 homologue RP105 aggravates outward remodeling in a murine model of arteriovenous fistula failure.

Bezhaeva T, Wong C, de Vries MR, van der Veer EP, van Alem CMA, Que I, Lalai RA, van Zonneveld AJ, Rotmans JI, Quax PHA.

Sci Rep. 2017 Aug 31;7(1):10269. doi: 10.1038/s41598-017-10108-4.

30.

A protective role of IRF3 and IRF7 signalling downstream TLRs in the development of vein graft disease via type I interferons.

Simons KH, Peters HAB, Jukema JW, de Vries MR, Quax PHA.

J Intern Med. 2017 Dec;282(6):522-536. doi: 10.1111/joim.12679. Epub 2017 Sep 27.

PMID:
28857295
31.

Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics.

Kooreman NG, de Almeida PE, Stack JP, Nelakanti RV, Diecke S, Shao NY, Swijnenburg RJ, Sanchez-Freire V, Matsa E, Liu C, Connolly AJ, Hamming JF, Quax PHA, Brehm MA, Greiner DL, Shultz LD, Wu JC.

Cell Rep. 2017 Aug 22;20(8):1978-1990. doi: 10.1016/j.celrep.2017.08.003.

32.

Inhibition of Mef2a Enhances Neovascularization via Post-transcriptional Regulation of 14q32 MicroRNAs miR-329 and miR-494.

Welten SMJ, de Vries MR, Peters EAB, Agrawal S, Quax PHA, Nossent AY.

Mol Ther Nucleic Acids. 2017 Jun 16;7:61-70. doi: 10.1016/j.omtn.2017.03.003. Epub 2017 Mar 14.

33.

Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis.

Welten SMJ, de Jong RCM, Wezel A, de Vries MR, Boonstra MC, Parma L, Jukema JW, van der Sluis TC, Arens R, Bot I, Agrawal S, Quax PHA, Nossent AY.

Atherosclerosis. 2017 Jun;261:26-36. doi: 10.1016/j.atherosclerosis.2017.04.011. Epub 2017 Apr 13.

34.

Plaque angiogenesis and intraplaque hemorrhage in atherosclerosis.

Parma L, Baganha F, Quax PHA, de Vries MR.

Eur J Pharmacol. 2017 Dec 5;816:107-115. doi: 10.1016/j.ejphar.2017.04.028. Epub 2017 Apr 21. Review.

35.

von Willebrand factor deficiency leads to impaired blood flow recovery after ischaemia in mice.

de Vries MR, Peters EAB, Quax PHA, Nossent AY.

Thromb Haemost. 2017 Jun 28;117(7):1412-1419. doi: 10.1160/TH16-12-0957. Epub 2017 Apr 6.

PMID:
28382367
36.

High-throughput identification of small molecules that affect human embryonic vascular development.

Vazão H, Rosa S, Barata T, Costa R, Pitrez PR, Honório I, de Vries MR, Papatsenko D, Benedito R, Saris D, Khademhosseini A, Quax PH, Pereira CF, Mercader N, Fernandes H, Ferreira L.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):E3022-E3031. doi: 10.1073/pnas.1617451114. Epub 2017 Mar 27.

37.

PX-18 Protects Human Saphenous Vein Endothelial Cells under Arterial Blood Pressure.

Kupreishvili K, Stooker W, Emmens RW, Vonk ABA, Sipkens JA, van Dijk A, Eijsman L, Quax PH, van Hinsbergh VWM, Krijnen PAJ, Niessen HWM.

Ann Vasc Surg. 2017 Jul;42:293-298. doi: 10.1016/j.avsg.2016.10.063. Epub 2017 Mar 11.

PMID:
28300679
38.

CCR7-CCL19/CCL21 Axis is Essential for Effective Arteriogenesis in a Murine Model of Hindlimb Ischemia.

Nossent AY, Bastiaansen AJ, Peters EA, de Vries MR, Aref Z, Welten SM, de Jager SC, van der Pouw Kraan TC, Quax PH.

J Am Heart Assoc. 2017 Mar 8;6(3). pii: e005281. doi: 10.1161/JAHA.116.005281.

39.

Arterial Blood Pressure Induces Transient C4b-Binding Protein in Human Saphenous Vein Grafts.

Kupreishvili K, Meischl C, Vonk ABA, Stooker W, Eijsman L, Blom AM, Quax PHA, van Hinsbergh VWM, Niessen HWM, Krijnen PAJ.

Ann Vasc Surg. 2017 May;41:259-264. doi: 10.1016/j.avsg.2016.10.033. Epub 2017 Feb 3.

PMID:
28163174
40.

Plaque angiogenesis and its relation to inflammation and atherosclerotic plaque destabilization.

de Vries MR, Quax PH.

Curr Opin Lipidol. 2016 Oct;27(5):499-506. doi: 10.1097/MOL.0000000000000339. Review.

PMID:
27472406
41.

Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model.

Wong C, Bezhaeva T, Rothuizen TC, Metselaar JM, de Vries MR, Verbeek FP, Vahrmeijer AL, Wezel A, van Zonneveld AJ, Rabelink TJ, Quax PH, Rotmans JI.

Sci Rep. 2016 Jul 27;6:30439. doi: 10.1038/srep30439.

42.

Vein graft failure: from pathophysiology to clinical outcomes.

de Vries MR, Simons KH, Jukema JW, Braun J, Quax PH.

Nat Rev Cardiol. 2016 Aug;13(8):451-70. doi: 10.1038/nrcardio.2016.76. Epub 2016 May 19. Review.

PMID:
27194091
43.

Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response.

Wezel A, de Vries MR, Maassen JM, Kip P, Peters EA, Karper JC, Kuiper J, Bot I, Quax PHA.

Sci Rep. 2016 Apr 7;6:24248. doi: 10.1038/srep24248.

44.

Heat-killed Staphylococcus aureus reduces atherosclerosis by inducing anti-inflammatory macrophages.

Frodermann V, van Duijn J, van Puijvelde GH, van Santbrink PJ, Lagraauw HM, de Vries MR, Quax PH, Bot I, Foks AC, de Jager SC, Kuiper J.

J Intern Med. 2016 Jun;279(6):592-605. doi: 10.1111/joim.12484. Epub 2016 Feb 23.

45.

The multifactorial nature of microRNAs in vascular remodelling.

Welten SM, Goossens EA, Quax PH, Nossent AY.

Cardiovasc Res. 2016 May 1;110(1):6-22. doi: 10.1093/cvr/cvw039. Epub 2016 Feb 23. Review.

PMID:
26912672
46.

A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail.

Wong CY, de Vries MR, Wang Y, van der Vorst JR, Vahrmeijer AL, van Zonneveld AJ, Hamming JF, Roy-Chaudhury P, Rabelink TJ, Quax PH, Rotmans JI.

J Vis Exp. 2016 Feb 3;(108):e53294. doi: 10.3791/53294.

47.

CXCL1 microspheres: a novel tool to stimulate arteriogenesis.

Caolo V, Vries M, Zupancich J, Houben M, Mihov G, Wagenaar A, Swennen G, Nossent Y, Quax P, Suylen D, Dijkgraaf I, Molin D, Hackeng T, Post M.

Drug Deliv. 2016 Oct;23(8):2919-2926. Epub 2015 Dec 10.

PMID:
26651867
48.

Letter Regarding Article, "MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization".

Welten SM, Quax PH, Nossent AY.

Circulation. 2015 Dec 8;132(23):e375. doi: 10.1161/CIRCULATIONAHA.115.018275. No abstract available.

PMID:
26644255
49.

Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability.

Wezel A, Welten SM, Razawy W, Lagraauw HM, de Vries MR, Goossens EA, Boonstra MC, Hamming JF, Kandimalla ER, Kuiper J, Quax PH, Nossent AY, Bot I.

Ann Surg. 2015 Nov;262(5):841-7; discussion 847-8. doi: 10.1097/SLA.0000000000001466.

PMID:
26583674
50.

Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery Function.

Hakimzadeh N, Nossent AY, van der Laan AM, Schirmer SH, de Ronde MW, Pinto-Sietsma SJ, van Royen N, Quax PH, Hoefer IE, Piek JJ.

PLoS One. 2015 Sep 2;10(9):e0137035. doi: 10.1371/journal.pone.0137035. eCollection 2015.

Supplemental Content

Support Center